SCHEMBL6123333

SCHEMBL6123333

NCCCCC(N)C(=O)Oc1cc[c]cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GSR P00390 1/20 0.43
▸ DPP7 Q9UHL4 3/20 0.40
▸ DPP8 Q6V1X1 3/20 0.40
▸ DPP9 Q86TI2 2/20 0.40
▸ LTA4H P09960 1/20 0.39
▸ MMP2 P08253 2/20 0.37
▸ ITGB3 P05106 1/20 0.37
▸ ITGA2B P08514 1/20 0.37
▸ ERAP2 Q6P179 2/20 0.35
▸ LNPEP Q9UIQ6 1/20 0.35
▸ TERT O14746 3/20 0.34
▸ ERAP1 Q9NZ08 1/20 0.34
▸ ANPEP P15144 1/20 0.34
▸ MMP9 P14780 1/20 0.33
▸ GNAI3 P08754 1/20 0.33
▸ GNAO1 P09471 1/20 0.33
▸ GNAI1 P63096 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7775125 0.84 GSR (0.50) GSRDPP7DPP8DPP9LTA4H
SCHEMBL7775127 0.84 GSR (0.50) GSRDPP7DPP8DPP9LTA4H
SCHEMBL10339168 0.82 GSR (0.43) GSRDPP7DPP8DPP9LTA4H
SCHEMBL11906139 0.80 LTA4H (0.44) GSRDPP7DPP8DPP9LTA4H
SCHEMBL578977 0.77 ITGB3 (0.48) LTA4HMMP2ITGB3ITGA2B
SCHEMBL4423862 0.77 MMP2 (0.53) DPP8DPP9MMP2
SCHEMBL8740500 0.77 MMP2 (0.53) DPP8DPP9MMP2
SCHEMBL571283 0.77 ITGB3 (0.65) GSRLTA4HMMP2ITGB3ITGA2B
SCHEMBL16124585 0.77 THRB (0.48) GSRLTA4HITGB3ITGA2BERAP2
SCHEMBL2387943 0.77 MMP2 (0.53) DPP8DPP9MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2454261-B1 IMIDAZO[1,2-ALPHA]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE UNIV SIENA (IT) 2014-11-19 — — EP claimed
US-8546147-B2 Imidazo[1,2-α]pyrazin-3(7H)-one derivatives bearing a new electron-rich structure UNIVERSITA DEGLI STUDI DI SIENA (IT) 2013-10-01 — — US claimed
US-20120171703-A1 IMIDAZO[1,2-ALPHA]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE UNIVERSITÁ DEGLI STUDI DI SIENA (IT) 2012-07-05 — — US claimed
EP-2454261-A1 IMIDAZO[1,2-ALPHA]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE Universita Degli Studi di Siena (IT) 2012-05-23 — — EP claimed
EP-2454261-B1 IMIDAZO[1,2-ALPHA]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE UNIV SIENA (IT) 2014-11-19 — — EP disclosed
US-8546147-B2 Imidazo[1,2-α]pyrazin-3(7H)-one derivatives bearing a new electron-rich structure UNIVERSITA DEGLI STUDI DI SIENA (IT) 2013-10-01 — — US disclosed
US-20120171703-A1 IMIDAZO[1,2-ALPHA]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE UNIVERSITÁ DEGLI STUDI DI SIENA (IT) 2012-07-05 — — US disclosed
EP-2454261-A1 IMIDAZO[1,2-ALPHA]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE Universita Degli Studi di Siena (IT) 2012-05-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120171703-A1 IMIDAZO[1,2-ALPHA]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE GLB1, NDUFV1, IK GSR 556/4885DPP7 910/4885DPP8 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback